Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Sexually Transmitted Diseases

  Free Subscription


30.12.2018

1 Clin Infect Dis
1 J Infect Dis
1 Oral Oncol
3 PLoS One
6 Sex Transm Infect


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Clin Infect Dis

  1. MEHANNA H, Bryant TS, Babrah J, Louie K, et al
    Human papillomavirus (HPV) vaccine effectiveness and potential herd immunity for reducing oncogenic oropharyngeal HPV16 prevalence in the UK; a cross-sectional study.
    Clin Infect Dis. 2018 Dec 22. pii: 5257796. doi: 10.1093/cid/ciy1081.
    PubMed     Text format     Abstract available


    J Infect Dis

  2. MENA M, Taberna M, Monfil L, Arbyn M, et al
    May oral HPV in healthy individuals explain differences in HPV-attributable fractions in oropharyngeal cancer? A systematic review and meta-analysis.
    J Infect Dis. 2018 Dec 22. pii: 5257869. doi: 10.1093.
    PubMed     Text format     Abstract available


    Oral Oncol

  3. JAYARAJ R, Kumarasamy C
    Comment on, "Survival for HPV-positive oropharyngeal squamous cell carcinoma with surgical versus non-surgical treatment approach: A systematic review and meta-analysis".
    Oral Oncol. 2018 Dec 19. pii: S1368-8375(18)30483.
    PubMed     Text format    


    PLoS One

  4. BAYER L, Gumpel J, Hause G, Muller M, et al
    Non-human papillomaviruses for gene delivery in vitro and in vivo.
    PLoS One. 2018;13:e0198996.
    PubMed     Text format     Abstract available

  5. NYARI S, Khan SA, Rawlinson G, Waugh CA, et al
    Vaccination of koalas (Phascolarctos cinereus) against Chlamydia pecorum using synthetic peptides derived from the major outer membrane protein.
    PLoS One. 2018;13:e0200112.
    PubMed     Text format     Abstract available

  6. ANDERSSON S, Belkic K, Mints M, Ostensson E, et al
    Is self-sampling to test for high-risk papillomavirus an acceptable option among women who have been treated for high-grade cervical intraepithelial neoplasia?
    PLoS One. 2018;13:e0199038.
    PubMed     Text format     Abstract available


    Sex Transm Infect

  7. BARNARD S, Free C, Bakolis I, Turner KME, et al
    Comparing the characteristics of users of an online service for STI self-sampling with clinic service users: a cross-sectional analysis.
    Sex Transm Infect. 2018;94:377-383.
    PubMed     Text format     Abstract available

  8. CORNELISSE VJ, Walker S, Phillips T, Hocking JS, et al
    Risk factors for oropharyngeal gonorrhoea in men who have sex with men: an age-matched case-control study.
    Sex Transm Infect. 2018;94:359-364.
    PubMed     Text format     Abstract available

  9. OMORI R, Nagelkerke N, Abu-Raddad LJ
    HIV and herpes simplex virus type 2 epidemiological synergy: misguided observational evidence? A modelling study.
    Sex Transm Infect. 2017 Dec 4. pii: sextrans-2017-053336.
    PubMed     Text format     Abstract available

  10. CAUSER LM, Guy RJ, Tabrizi SN, Whiley DM, et al
    Molecular test for chlamydia and gonorrhoea used at point of care in remote primary healthcare settings: a diagnostic test evaluation.
    Sex Transm Infect. 2018;94:340-345.
    PubMed     Text format     Abstract available

  11. LANGENDORF C, Lastrucci C, Sanou-Bicaba I, Blackburn K, et al
    Dual screen and confirm rapid test does not reduce overtreatment of syphilis in pregnant women living in a non-venereal treponematoses endemic region: a field evaluation among antenatal care attendees in Burkina Faso.
    Sex Transm Infect. 2018 Dec 22. pii: sextrans-2018-053722.
    PubMed     Text format     Abstract available

  12. OWUSU C, Baker KM, Paul R, Curtis AB, et al
    Modelling individual vulnerability to sexually transmitted infections to optimise intervention strategies: analysis of surveillance data from Kalamazoo County, Michigan, USA.
    Sex Transm Infect. 2018;94:353-358.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sexually Transmitted Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: